Debiopharm, a Swiss biopharmaceutical company, develops innovative therapies that target high unmet medical needs in oncology and infectious diseases. Bridging the gap between disruptive discovery products and international patient reach, we identify high-potential compounds and technologies for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
